Login to Your Account



Lilly Investing $440M in Second Irish Biopharmaceutical Facility

By Cormac Sheridan
Staff Writer

Wednesday, February 29, 2012
DUBLIN, Ireland – Shrugging off uncertainties stemming from a string of recent – and looming – patent expiries, Eli Lilly and Co. is investing €330 million (US$443 million) in a new biopharmaceutical production facility at its Dunderrow campus, which is located near Kinsale, in County Cork, Ireland.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription